Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

338 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 338 results

Not applicableUnknownNCT04273477
What this trial is testing

Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Large-scale testing (Phase 3)Study completedNCT06775652
What this trial is testing

Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Yongtao Han 254
Testing effectiveness (Phase 2)Study completedNCT00787371
What this trial is testing

Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 69
Not applicableUnknownNCT03548844
What this trial is testing

Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy

Who this might be right for
Rectal CancerSurgery
Yanhong Deng 326
Testing effectiveness (Phase 2)Study completedNCT00858806
What this trial is testing

Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy

Who this might be right for
Chronic Myeloid Leukemia
Università degli Studi di Brescia 78
Testing effectiveness (Phase 2)Study completedNCT03188393
What this trial is testing

Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery

Who this might be right for
Invasive Breast CarcinomaStage II Breast CancerStage IIA Breast Cancer+2 more
NRG Oncology 105
Large-scale testing (Phase 3)Looking for participantsNCT06312137
What this trial is testing

Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Who this might be right for
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC 780
Testing effectiveness (Phase 2)UnknownNCT03638648
What this trial is testing

Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 80
Not applicableNot Yet RecruitingNCT07475338
What this trial is testing

Effect of Storytelling on Questionnaire Completion and Quality of Collected Data in an E-Cohort

Who this might be right for
General Population (no Specific Condition or Disease)
SKEZI 500
Testing effectiveness (Phase 2)UnknownNCT02885766
What this trial is testing

Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene

Who this might be right for
Chronic Myeloid LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Fusion Pharma LLC 65
Post-approval studies (Phase 4)Study completedNCT01227577
What this trial is testing

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Who this might be right for
Chronic Myelogenous Leukemia in Chronic Phase
Novartis Pharmaceuticals 128
Not applicableUnknownNCT04278274
What this trial is testing

Post-Neoadjuvant Treatment MRI Based AI System to Predict pCR for Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 205
Not applicableLooking for participantsNCT05976815
What this trial is testing

Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients

Who this might be right for
Breast Cancer
University Institute of Maia 86
Not applicableStudy completedNCT04298619
What this trial is testing

Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

Who this might be right for
Hodgkin LymphomaHigh RiskRelapse
Federico II University 123
Post-approval studies (Phase 4)Looking for participantsNCT07268313
What this trial is testing

Complete Remission After Treatment With Biologics for Nasal Polyps

Who this might be right for
Nasal Polyps
Rigshospitalet, Denmark 66
Large-scale testing (Phase 3)Study completedNCT01535391
What this trial is testing

Nilotinib in PH+, BCR-, ABL+ CML Patients

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 109
Not applicableStudy completedNCT06854107
What this trial is testing

Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

Who this might be right for
Pathologic Complete Response
Zilong Yuan 225
Testing effectiveness (Phase 2)Study completedNCT01914900
What this trial is testing

Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Who this might be right for
Locally Advanced Resectable Oral Cavity Squamous Cell Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Large-scale testing (Phase 3)Not Yet RecruitingNCT07321847
What this trial is testing

Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer (CRC)Colon Cancer Liver MetastasesRectal Cancer+2 more
Immunophotonics, Inc. 717
Testing effectiveness (Phase 2)WithdrawnNCT06180863
What this trial is testing

Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia
Yale University
Load More Results